Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Organoplatinum Compounds. Found 9 abstracts

Fakhry C, Zhang Q, Nguyen-Tan PF, Rosenthal DI, Weber RS, Lambert L, Trotti AM, Barrett WL, Thorstad WL, Jones CU, Yom SS, Wong SJ, Ridge JA, Rao SS, Bonner JA, Vigneault E, Raben D, Kudrimoti MR, Harris J, Le QT, Gillison ML. Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer. J Clin Oncol. 2017 Dec 20;35(36):4057-65.   PMCID: PMC5736236
Overman MJ, Morris V, Moinova H, Manyam G, Ensor J, Lee MS, Eng C, Kee B, Fogelman D, Shroff RT, LaFramboise T, Mazard T, Feng T, Hamilton S, Broom B, Lutterbaugh J, Issa JP, Markowitz SD, Kopetz S. Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin. Oncotarget. 2016 Oct 11;7(41):67495-506.   PMCID: PMC5341892
Marks EI, Brennan M, El-Deiry WS. Correlation of CEA but not CA 19-9 as serum biomarkers of disease activity in a case of metastatic rectal adenocarcinoma. Cancer Biology & Therapy. 2015 Aug;16(8):1136-9.   PMCID: 4622690
Wong SJ, Moughan J, Meropol NJ, Anne PR, Kachnic LA, Rashid A, Watson JC, Mitchell EP, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG. Efficacy Endpoints of Radiation Therapy Group Protocol 0247: A Randomized, Phase 2 Study of Neoadjuvant Radiation Therapy Plus Concurrent Capecitabine and Irinotecan or Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer. International Journal of Radiation Oncology Biology Physics. 2015 Jan;91(1):116-23.   PMCID: 4385459
Burger RA, Brady MF, Bookman MA, Monk BJ, Walker JL, Homesley HD, Fowler J, Greer BE, Boente M, Fleming GF, Lim PC, Rubin SC, Katsumata N, Liang SX. Risk factors for GI adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced ovarian cancer: A Gynecologic Oncology Group Study. J Clin Oncol. 2014 Apr 20;32(12):1210-7.   PMCID: Pmc3986384
Thomay AA, Nagorney DM, Cohen SJ, Sigurdson ER, Truty MJ, Burtness B, Hall MJ, Chun YS. Modern chemotherapy mitigates adverse prognostic effect of regional nodal metastases in stage IV colorectal cancer. J Gastrointest Surg. 2014 Jan;18(1):69-74.
Dotan E, Meropol NJ, Burtness B, Denlinger CS, Lee J, Mintzer D, Zhu F, Ruth K, Tuttle H, Sylvester J, Cohen SJ. A phase II study of capecitabine, oxaliplatin, and cetuximab with or without bevacizumab as frontline therapy for metastatic colorectal cancer. A Fox Chase extramural research study. J Gastrointest Cancer. 2012 Dec;43(4):562-9.   PMCID: 3400721
Parmar MK, Barthel FM, Sydes M, Langley R, Kaplan R, Eisenhauer E, Brady M, James N, Bookman MA, Swart AM, Qian W, Royston P. Speeding up the evaluation of new agents in cancer. Journal of the National Cancer Institute. 2008 Sep 03;100(17):1204-14.   PMCID: PMC2528020
Engstrom PF, Benson AB, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ, National Comprehensive Cancer N. Rectal cancer clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2005 Jul;3(4):492-508.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Organoplatinum Compounds

Organoplatinum Compounds Antineoplastic Combined Chemotherapy Protocols therapeutic use Middle Aged Female Male administration & dosage pathology drug therapy Aged Adult Disease-Free Survival Fluorouracil Rectal Neoplasms Ovarian Neoplasms Colorectal Neoplasms adverse effects Neoplasm Staging analogs & derivatives Leucovorin Camptothecin Liver Neoplasms Young Adult methods Kaplan-Meier Estimate Antineoplastic Agents Monoclonal Antibodies-Humanized Prognosis Randomized Controlled Trials as Topic Lymphatic Metastasis 80 and over Aged Chemoradiotherapy Deoxycytidine therapy Survival Analysis Capecitabine Adenocarcinoma Lung Neoplasms mortality blood Tumor Biomarkers Monoclonal Antibodies tu [Therapeutic Neoadjuvant Therapy Cea Lymph Nodes Retrospective Studies Radiosurgery Hepatectomy Cohort Studies Adolescent Nomograms Neoplasm Drug Resistance 7689-03-4 (Camptothecin) Predictive Value of Tests United States CpG Islands vimentin Carcinoembryonic Antigen Cimp radiotherapy diagnosis di [Diagnosis] 0 (Antineoplastic Combined Chemotherapy Protocols) 0 (Organoplatinum Compounds) 58-05-9 (Leucovorin) Research Design chemically induced 0 (Folfox protocol) tumor marker 51-21-8 (Fluorouracil) Squamous Cell Carcinoma DNA Methylation Ca 19-9 Risk Factors Oropharyngeal Neoplasms su [Surgery] United States Food and Drug Administration CA-19-9 Antigen surgery secondary aa [Analogs & Derivatives] Drug Approval Peritoneal Neoplasms Phase II Clinical Trials as Topic Survival Rate azacitidine st [Standards] Radiation-Sensitizing Agents Azacitidine Medical Oncology Use] 0 (IFL protocol) Clinical Trials as Topic tu [Therapeutic Use] Adjuvant Radiotherapy Salvage Therapy Logistic Models Proportional Hazards Models Taxoids sc [Secondary] Gastrointestinal Diseases Prostatic Neoplasms colorectal cancer rt [Radiotherapy] methylation Time Factors Drug Administration Schedule Vimentin Treatment Outcome drug effects dt [Drug Therapy] Radiotherapy Dosage Neoplasms Sample Size Phase III Clinical Trials as Topic metastatic colorectal adenocarcinoma Head and Neck Neoplasms Double-Blind Method
Last updated on Wednesday, March 04, 2020